IntelGenx is a leading oral drug delivery company focused on the development and manufacturing of innovative pharmaceutical films based on its proprietary VersaFilm™ technology platform. Established in 2003, we are based in Montreal, Canada and listed on the TSX-V and OTC-QX.
Our mission is to make approved drugs better, with next generation pharmaceutical products that address unmet medical needs, and offer significant benefits to patients and physicians.
IntelGenx' highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, intellectual property, regulatory and manufacturing services. We Offer:
• Development and Manufacturing by Contract •
• Licensing-Out of Innovative Oral Film Products •